Karolin Trautmann‐Grill

Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study

Srđan Verstovšek, Aaron T. Gerds, Alessandro M. Vannucchi et al. · The Lancet · 2023 · 185 citations

Medicine, Hematology, Pharmacology +9

Adoptive transfer of allogeneic regulatory T cells into patients with chronic graft-versus-host disease

Anke Theil, Sebastian Tuve, Uta Oelschlägel et al. · Cytotherapy · 2015 · 178 citations

Life Sciences, Immunology, Clinical Immunology +15

Nivolumab and Doxorubicin, Vinblastine, and Dacarbazine in Early-Stage Unfavorable Hodgkin Lymphoma: Final Analysis of the Randomized German Hodgkin Study Group Phase II NIVAHL Trial

Paul J. Bröckelmann, Ina Bühnen, Karolin Trautmann‐Grill et al. · Journal of Clinical Oncology · 2022 · 92 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Isatuximab, Lenalidomide, Bortezomib, and Dexamethasone Induction Therapy for Transplant-Eligible Newly Diagnosed Multiple Myeloma: Final Part 1 Analysis of the GMMG-HD7 Trial

K. Elias, Uta Bertsch, Ema Požek et al. · Journal of Clinical Oncology · 2024 · 62 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Emicizumab prophylaxis in patients with acquired haemophilia A (GTH-AHA-EMI): an open-label, single-arm, multicentre, phase 2 study

Andreas Tiede, Christina Hart, Paul Knöbl et al. · The Lancet Haematology · 2023 · 58 citations

Medicine, Hematology, Pharmacotherapy +3